Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN-BLMF for Product used for unknown indication: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 64 adverse event reports in the FDA FAERS database where BELANTAMAB MAFODOTIN-BLMF was used for Product used for unknown indication.

Most Reported Side Effects for BELANTAMAB MAFODOTIN-BLMF

Side Effect Reports % Deaths Hosp.
Death 32 21.3% 32 2
Plasma cell myeloma 15 10.0% 8 2
Keratopathy 11 7.3% 3 1
Visual impairment 11 7.3% 0 0
Ocular toxicity 10 6.7% 0 0
Condition aggravated 9 6.0% 4 1
Plasma cell myeloma refractory 9 6.0% 2 1
Disease progression 7 4.7% 2 0
Dry eye 7 4.7% 0 0
Fatigue 7 4.7% 3 2
Visual acuity reduced 7 4.7% 0 0
Corneal disorder 6 4.0% 1 0
Therapy cessation 6 4.0% 3 0
Corneal epithelial microcysts 5 3.3% 1 0
Hypercalcaemia 5 3.3% 0 5

Other Indications for BELANTAMAB MAFODOTIN-BLMF

Plasma cell myeloma (68) Plasma cell myeloma refractory (11)

Other Drugs Used for Product used for unknown indication

OXYCODONE (129,391) ADAPALENE (91,681) APIXABAN (88,417) ETANERCEPT (71,866) SACUBITRIL\VALSARTAN (69,693) ACETAMINOPHEN (68,427) AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206) ADALIMUMAB (63,549) EVOLOCUMAB (60,696) MORPHINE (59,440)

Related Pages

BELANTAMAB MAFODOTIN-BLMF Full Profile All Product used for unknown indication Drugs BELANTAMAB MAFODOTIN-BLMF Demographics BELANTAMAB MAFODOTIN-BLMF Timeline